Displaying assets from 1 to 30 out of 1
- License Type
- Rights Managed
Description PLT CD62P expression is reduced on PRT‐treated PLTs after coculture with PBMNCs. CD62P surface expression was measured by flow cytometry on untreated (■) and PRT‐treated () PLTs after 5 days of...
- Rights Holder
- John Wiley & Sons, Inc.
Article Title: Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat–derived platelet concentrates
Publication Title: Transfusion